AUTHOR=Pochwat Bartłomiej , Szewczyk Bernadeta , Kotarska Katarzyna , Rafało-Ulińska Anna , Siwiec Marcin , Sowa Joanna E. , Tokarski Krzysztof , Siwek Agata , Bouron Alexandre , Friedland Kristina , Nowak Gabriel TITLE=Hyperforin Potentiates Antidepressant-Like Activity of Lanicemine in Mice JOURNAL=Frontiers in Molecular Neuroscience VOLUME=11 YEAR=2018 URL=https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2018.00456 DOI=10.3389/fnmol.2018.00456 ISSN=1662-5099 ABSTRACT=
N-methyl-D-aspartate receptor (NMDAR) modulators induce rapid and sustained antidepressant like-activity in rodents through a molecular mechanism of action that involves the activation of Ca2+ dependent signaling pathways. Moreover, ketamine, a global NMDAR antagonist is a potent, novel, and atypical drug that has been successfully used to treat major depressive disorder (MDD). However, because ketamine evokes unwanted side effects, alternative strategies have been developed for the treatment of depression. The objective of the present study was to determine the antidepressant effects of either a single dose of hyperforin or lanicemine vs. their combined effects in mice. Hyperforin modulates intracellular Ca2+ levels by activating Ca2+-conducting non-selective canonical transient receptor potential 6 channel (TRPC6) channels. Lanicemine, on the other hand, blocks NMDARs and regulates Ca2+ dependent processes. To evaluate the antidepressant-like activity of hyperforin and lanicemine, a set of